187 related articles for article (PubMed ID: 28246398)
1. A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy.
Bot I; Ortiz Zacarías NV; de Witte WE; de Vries H; van Santbrink PJ; van der Velden D; Kröner MJ; van der Berg DJ; Stamos D; de Lange EC; Kuiper J; IJzerman AP; Heitman LH
Sci Rep; 2017 Mar; 7(1):52. PubMed ID: 28246398
[TBL] [Abstract][Full Text] [Related]
2. AMPK activation reduces the number of atheromata macrophages in ApoE deficient mice.
Wang J; Ma A; Zhao M; Zhu H
Atherosclerosis; 2017 Mar; 258():97-107. PubMed ID: 28235712
[TBL] [Abstract][Full Text] [Related]
3. Map3k8 Modulates Monocyte State and Atherogenesis in ApoE-/- Mice.
Sanz-Garcia C; Sánchez Á; Contreras-Jurado C; Cales C; Barranquero C; Muñoz M; Merino R; Escudero P; Sanz MJ; Osada J; Aranda A; Alemany S
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):237-246. PubMed ID: 27856455
[TBL] [Abstract][Full Text] [Related]
4. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.
Veillard NR; Steffens S; Pelli G; Lu B; Kwak BR; Gerard C; Charo IF; Mach F
Circulation; 2005 Aug; 112(6):870-8. PubMed ID: 16061736
[TBL] [Abstract][Full Text] [Related]
5. CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE(-/-) mice.
Aiello RJ; Perry BD; Bourassa PA; Robertson A; Weng W; Knight DR; Smith AH; Frederick KS; Kalgutkar A; Gladue RP
Atherosclerosis; 2010 Feb; 208(2):370-5. PubMed ID: 19837409
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessment.
Olzinski AR; Turner GH; Bernard RE; Karr H; Cornejo CA; Aravindhan K; Hoang B; Ringenberg MA; Qin P; Goodman KB; Willette RN; Macphee CH; Jucker BM; Sehon CA; Gough PJ
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):253-9. PubMed ID: 19965779
[TBL] [Abstract][Full Text] [Related]
7. A CCR2/CCR5 antagonist attenuates an increase in angiotensin II-induced CD11b+ monocytes from atherogenic ApoE-/- mice.
Major TC; Olszewski B; Rosebury-Smith WS
Cardiovasc Drugs Ther; 2009 Apr; 23(2):113-20. PubMed ID: 19052854
[TBL] [Abstract][Full Text] [Related]
8. Corosolic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice by regulating the nuclear factor-κB signaling pathway and inhibiting monocyte chemoattractant protein-1 expression.
Chen H; Yang J; Zhang Q; Chen LH; Wang Q
Circ J; 2012; 76(4):995-1003. PubMed ID: 22293444
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
Bursill CA; Castro ML; Beattie DT; Nakhla S; van der Vorst E; Heather AK; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1773-8. PubMed ID: 20702809
[TBL] [Abstract][Full Text] [Related]
10. Everolimus limits aortic aneurysm in the apolipoprotein E-deficient mouse by downregulating C-C chemokine receptor 2 positive monocytes.
Moran CS; Jose RJ; Moxon JV; Roomberg A; Norman PE; Rush C; Körner H; Golledge J
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):814-21. PubMed ID: 23393391
[TBL] [Abstract][Full Text] [Related]
11. A novel C-C chemokine receptor 2 antagonist prevents progression of albuminuria and atherosclerosis in mouse models.
Okamoto M; Fuchigami M; Suzuki T; Watanabe N
Biol Pharm Bull; 2012; 35(11):2069-74. PubMed ID: 23123476
[TBL] [Abstract][Full Text] [Related]
12. Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes.
Soehnlein O; Drechsler M; Döring Y; Lievens D; Hartwig H; Kemmerich K; Ortega-Gómez A; Mandl M; Vijayan S; Projahn D; Garlichs CD; Koenen RR; Hristov M; Lutgens E; Zernecke A; Weber C
EMBO Mol Med; 2013 Mar; 5(3):471-81. PubMed ID: 23417922
[TBL] [Abstract][Full Text] [Related]
13. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
14. Visualization of Monocytic Cells in Regressing Atherosclerotic Plaques by Intravital 2-Photon and Positron Emission Tomography-Based Imaging-Brief Report.
Li W; Luehmann HP; Hsiao HM; Tanaka S; Higashikubo R; Gauthier JM; Sultan D; Lavine KJ; Brody SL; Gelman AE; Gropler RJ; Liu Y; Kreisel D
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1030-1036. PubMed ID: 29567678
[TBL] [Abstract][Full Text] [Related]
15. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
16. Maternal diet supplemented with methyl-donors protects against atherosclerosis in F1 ApoE(-/-) mice.
Delaney C; Garg SK; Fernandes C; Hoeltzel M; Allen RH; Stabler S; Yung R
PLoS One; 2013; 8(2):e56253. PubMed ID: 23437105
[TBL] [Abstract][Full Text] [Related]
17. CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease.
Parker R; Weston CJ; Miao Z; Corbett C; Armstrong MJ; Ertl L; Ebsworth K; Walters MJ; Baumart T; Newland D; McMahon J; Zhang P; Singh R; Campbell J; Newsome PN; Charo I; Schall TJ; Adams DH
Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G483-G493. PubMed ID: 29420066
[TBL] [Abstract][Full Text] [Related]
18. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
[TBL] [Abstract][Full Text] [Related]
19. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice.
Dawson TC; Kuziel WA; Osahar TA; Maeda N
Atherosclerosis; 1999 Mar; 143(1):205-11. PubMed ID: 10208497
[TBL] [Abstract][Full Text] [Related]
20. Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient mice.
Wang L; Wang W; Shah PK; Song L; Yang M; Sharifi BG
Cardiovasc Pathol; 2012; 21(5):398-413. PubMed ID: 22300502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
